Immunocore Holdings plc American Depositary Shares - IMCR STOCK NEWS
Immunocore Holdings plc (NASDAQ: IMCR) develops TCR bispecific immunotherapies for cancer, infectious, and autoimmune diseases using its ImmTAC platform. Notable products include KIMMTRAK for metastatic uveal melanoma. Recent collaborations include a Phase 3 trial with Bristol Myers Squibb for advanced cutaneous melanoma. The company's pipeline includes programs for HBV and solid tumors, with a mission to improve patient outcomes.
Reference News
Immunocore Holdings plc (NASDAQ: IMCR) develops TCR bispecific immunotherapies for cancer, infectious, and autoimmune diseases using its ImmTAC platform. Notable products include KIMMTRAK for metastatic uveal melanoma. Recent collaborations include a Phase 3 trial with Bristol Myers Squibb for advanced cutaneous melanoma. The company's pipeline includes programs for HBV and solid tumors, with a mission to improve patient outcomes.